SCHEMBL10558162

SCHEMBL10558162

O=C1COCc2ncccc2N1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 1/20 0.40
▸ PLCG1 P19174 1/20 0.39
▸ PDE3B Q13370 1/20 0.38
▸ PDE3A Q14432 1/20 0.38
▸ GSK3B P49841 6/20 0.38
▸ CDK5 Q00535 5/20 0.38
▸ CDK5R1 Q15078 5/20 0.38
▸ GSK3A P49840 4/20 0.38
▸ CYP11B1 P15538 1/20 0.38
▸ CYP11B2 P19099 1/20 0.38
▸ KDR P35968 2/20 0.37
▸ CCNB2 O95067 2/20 0.37
▸ CDK1 P06493 2/20 0.37
▸ CCNB1 P14635 2/20 0.37
▸ CCNB3 Q8WWL7 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ AHR P35869 1/20 0.35
▸ PDK2 Q15119 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL659375 0.78 AHR (0.48) BRD4PLCG1PDE3BPDE3AGSK3B
SCHEMBL29550002 0.78 AHR (0.48) BRD4PLCG1PDE3BPDE3AGSK3B
SCHEMBL3053419 0.77 MAPT (0.53) BRD4PLCG1PDE3BPDE3AGSK3B
SCHEMBL2066798 0.77 CYP11B1 (0.44) BRD4PLCG1PDE3BPDE3AGSK3B
SCHEMBL2233893 0.77 NPC1 (0.50) BRD4PLCG1PDE3BPDE3AGSK3B
SCHEMBL30493623 0.77 NPC1 (0.50) BRD4PLCG1PDE3BPDE3AGSK3B
SCHEMBL279914 0.74 CYP11B1 (0.44) GSK3BCDK5CDK5R1GSK3ACYP11B1
SCHEMBL29561576 0.74 CYP11B1 (0.44) GSK3BCDK5CDK5R1GSK3ACYP11B1
SCHEMBL12387707 0.73 MAPT (0.43) BRD4PLCG1MAPTAHRPDK2
Hydrochloric Acid SCHEMBL30693477 0.72 CYP11B1 (0.43) GSK3BCDK5CDK5R1GSK3ACYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4866074-A Naphtheridinone- and pyridooxazinone-pyridone compounds, cardiotonic compositions including same, and their uses RORER PHARMACEUTICAL CORPORATION (US) 1989-09-12 — — US disclosed
US-4829066-A CONGESTIVE HEART FAILURE RORER PHARMACEUTICAL CORPORATION (US) 1989-05-09 — — US disclosed
US-4822794-A Pyridooxazinone-pyridone compounds, cardiotonic compositions including the same, and their uses RORER PHARMACEUTICAL CORPORATION (US) 1989-04-18 — — US disclosed
Send feedback